The UW/FHCRC CFAR recompeted in 2002, received a score of 130, and was refunded at $1.5M per year 3/1/03. Our 2002 application requested $2.5M per year for core budgets for years 2-5 contingent on raising the CFAR funding Cap. Our CFAR is now eligible for base award funding up to $3M per year beginning 2004. This application thus contains (1) our 2002 application with the proposed core enhancements and new services and related budget requests for years 2-5 now highlighted in bold italics; (2) a new summary of these enhancements, new services and related budget requests at the front of the CFAR Research Plan, together with each core's responses to core-specific concerns expressed in the 2002 review Summary Statement; and (3) two proposed new CFAR Scientific Programs. OAR lists 163 HIV/AIDS awards to the UW, FHCRC, and affiliates from NIH in FY02 for $111,301,211 (134 awards for $91,449,746 were """"""""allowable"""""""" up from $9.1M in 1988 and $25.9M in 1997 and $79.4M in 2001). Strategic planning for HIV/AIDS program development has resulted in 180,000 sq. ft. of new or renovated space since 1997 for CFAR members at the UW, FHCRC, and affiliated institutions. Our CFAR has 249 members and 66 trainees. This application includes 10 funded Cores: A) Administration, B) Development, C) Biostatistics; D) Clinical Research, which will collaborate with other cores to establish an HIV Specimen Repository Subcore; and will sponsor pilot grants for use of this repository and of the Core G clinical data base; E) International Research, which will begin a new Subcore for HIV/AIDS research and research training in Women and Children; F) Clinical Retrovirology; G) Health Services Research; H) Genomics, supports new microarray and bioinformatics research; I) Molecular Immunology, which will add BIACORE facilities for studying HIV envelope interactions with antibodies and receptors; and J) SocioBehavioral and Prevention Research, a new core, added to support increasing numbers of behavioral and prevention research projects at the UW. Two new CFAR Scientific Programs are proposed: Program 1, Mathematical Modeling for HIV/STD Research, includes the new component project: Multilevel Intervention Strategies for HIV Prevention: Mathematical Modeling for Efficacy Trials. Program 2, HIV-1 Research in Women, includes the new component project: HIV-1 Pathogenesis and Treatment in Women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027757-17S3
Application #
6764543
Study Section
Special Emphasis Panel (ZAI1-AR-A (J3))
Program Officer
Namkung, Ann S
Project Start
1997-03-01
Project End
2008-02-29
Budget Start
2004-04-01
Budget End
2005-02-28
Support Year
17
Fiscal Year
2004
Total Cost
$1,348,837
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
Ronen, Keshet; Unger, Jennifer A; Drake, Alison L et al. (2018) SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content. AIDS Care 30:500-505

Showing the most recent 10 out of 1275 publications